Image

    Pharmacologic Treatment of Polycystic Ovary Syndrome

    January 2003 in “ Seminars in reproductive medicine
    David A. Ehrmann, Daniel F. Rychlik
    Studysummary This review outlines the underlying pathophysiology and treatment options for the androgen excess and reproductive and metabolic manifestations of polycystic ovary syndrome, but reports no clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on thieme-connect.de →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Diagnosis and Therapy of Hyperandrogenism Baillière's clinical obstetrics and gynaecology · 1997
    2. Comparison of Sequential Cyproterone Acetate/Estrogen Versus Spironolactone/Oral Contraceptive in the Treatment of Hirsutism ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 1991
    3. Treatment of Hirsutism with the Pure Antiandrogen Flutamide Journal of the American Academy of Dermatology · 1990
    4. Spironolactone Is an Effective and Well-Tolerated Systemic Antiandrogen Therapy for Hirsute Women The Journal of Clinical Endocrinology & Metabolism · 1989
    5. Androgen Metabolism in Hirsute Patients Treated with Cyproterone Acetate Journal of steroid biochemistry/Journal of Steroid Biochemistry · 1984
    6. Treatment of Hirsutism With Spironolactone JAMA · 1982

    Related research 3

    1. The Treatment of Polycystic Ovary Syndrome and Systematization of Knowledge: Literature Review Journal of Education Health and Sport · 2022
    2. Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Hair Loss Springer eBooks · 2013
    3. Polycystic Ovary Syndrome and Acne Skin therapy letter · 2011